Genmab Announces Data to be Presented at 2018 ASCO Annual Meeting

    NEXT STORY
    Immunomedics Announces Oral Presentation of Sacituzumab Govitecan in Hormone Receptor-Positive (HR+) Metastatic Breast Cancer (mBC) at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
    PREV STORY
    Teladoc Announces U.S. Launch of Behavioral Health Navigator
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    G1 Therapeutics Announces Proposed Offering of Common Stock

    RESEARCH TRIANGLE PARK, N.C., March 05, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq:GTHX), ...

    author_avatar
    NASDAQ Market News

    Progenics Announces Publication of Pivotal Trial of AZEDRA® (iobenguane I 131) in The Journal of Nuclear Medicine

    NEW YORK, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology ...

    author_avatar
    NASDAQ Market News

    Oncology Venture ökar sitt ägande i dovitinib

    author_avatar
    NASDAQ Market News